scholarly journals e-Enabling International Cancer Research: Lessons Being Learnt in the ENS@T-CANCER Project

2013 ◽  
Author(s):  
Anthony Stell ◽  
Richard Sinnott
Keyword(s):  
Cancer Research ◽  
Cancer Project

Abstract 5371: The Metastatic Breast Cancer Project: Partnering with patients to accelerate progress in cancer research

2018 ◽  
Author(s):  
Nikhil Wagle ◽  
Corrie Painter ◽  
Elana Anastasio ◽  
Michael Dunphy ◽  
Mary McGillicuddy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Research ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Cancer Project

A Breast and Cervical Cancer Project in a Native Hawaiian Community: Wai′anae Cancer Research Project

1995 ◽  
Vol 24 (5) ◽  
pp. 447-453 ◽  
Author(s):  
R.O. Banner ◽  
H. Decambra ◽  
R. Enos ◽  
C. Gotay ◽  
O.W. Hammond ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Research ◽  
Native Hawaiian ◽  
Research Project ◽  
Breast And Cervical Cancer ◽  
Cancer Project

scholarly journals A Global Cancer Project Map Integrating Global Cancer Statistics to Guide International Efforts

2016 ◽  
Vol 2 (3_suppl) ◽  
pp. 9s-10s ◽  
Author(s):  
Ali Chisti ◽  
Nour Sharara ◽  
Manaswi Gupta ◽  
Jane Craycroft ◽  
Ilyana Rosenberg ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Research ◽  
National Cancer Institute ◽  
Conflicts Of Interest ◽  
Clinical Care ◽  
Cancer Control ◽  
Developed Countries ◽  
Cancer Type ◽  
Life Years ◽  
Cancer Project

Abstract 39 Background: In response to the growing burden of cancer, Global Oncology, Inc., and the National Cancer Institute Center for Global Health launched a free, online, interactive map, the Global Cancer Project Map (GCPM) [ http://gcpm.globalonc.org ], to allow policy makers, researchers, and civil society around the world to search this central repository of international cancer control and research projects. The GCPM serves to catalyze collaboration in cancer research and clinical care, as well as inform research and care gaps. Methods: In addition to search options by project attributes, the GCPM provides map overlays of epidemiological measures using IARC’s GLOBOCAN cancer-specific estimates of incidence, prevalence, and mortality, cancer disability--adjusted life years, and UN Human Development Index country values. Currently, the map displays projects with international collaborators collated from the NCI, NCI-Designated Cancer Centers, UICC and ASCO. Results: The GCPM search options offer countless angles of looking at projects worldwide. Of the 1,479 currently-mapped projects, 44.8% have investigators or collaborators in less-developed countries (LDCs) (as defined by the UN). Of the 1218 with a project type classification, 104 relate to capacity building and/or training, with 69 of these projects (66.3%) occurring in LDCs. Utilizing the cancer type search options, the GCPM currently displays 54 cervical cancer projects with LDC collaborators, where the cervical cancer mortality age--standardized risk is more than 2.5 times higher for LDCs than more-developed countries. Conclusions: The GCPM is a real-time needs assessment tool to allow the cancer community to visualize international efforts in cancer control and link need to action. To better address the growing burden of cancer, the partnership is actively seeking collaboration and additional project submissions. Utilized with cancer statistic overlays, the GCPM can help develop regional priorities in cancer research and control. Funding: This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST: Ali Chisti No relationship to disclose Nour Sharara No relationship to disclose Manaswi Gupta No relationship to disclose Jane Craycroft No relationship to disclose Ilyana Rosenberg Employment: Connance, Inc., Hayes Management Consulting Camille Morgan No relationship to disclose Kalina Duncan No relationship to disclose Rachel Abudu No relationship to disclose Billy Andre No relationship to disclose Shannon Silkenson No relationship to disclose Jennifer Silva No relationship to disclose Ami Bhatt No relationship to disclose Ted Trimble No relationship to disclose Franklin Huang Stock or Other Ownership: GlaxoSmithKline, Abbvie

scholarly journals Rede ONSA e o Projeto Genoma Humano do Câncer: Contribuição ao Genoma Humano

2002 ◽  
Vol 46 (4) ◽  
pp. 325-329 ◽  
Author(s):  
Edna T. Kimura ◽  
Gilson S. Baía
Keyword(s):  
Cancer Research ◽  
Human Genome ◽  
Gene Bank ◽  
Cancer Project

A contribuição maior da ciência brasileira ao genoma humano foi trazida pelo Projeto Genoma Humano do Câncer (Human Genome Cancer Project - HCGP) uma parceria da FAPESP e do Ludwig Institute for Cancer Research e desenvolvido por 29 diferentes laboratórios de seqüenciamento e um centro de bioinformática. Foram seqüenciados mais de 1 milhão de fragmentos gênicos expressos (expressed sequences tags, ESTs), provenientes de diferentes tumores humanos. Grande parte destes dados é de acesso público através da website do Gene Bank (<A HREF="http://www.ncbi.nlm.nih.gov/">www.ncbi.nlm.nig.gov</A>), mantido pelo NCBI - National Center for Biotechnology Information. Atualmente, diversos projetos estão em desenvolvimento utilizando informações geradas no HCGP e abrangem observar a expressão diferenciada dos genes em diferentes tumores, caracterização completa de genes específicos, assim como o estudo funcional e estrutural dos produtos protéicos. É promissora a perspectiva de que num futuro próximo, diferentes resultados provenientes destas investigações possam trazer benefícios preventivos, prognósticos e clínicos em câncer e outras doenças.

scholarly journals Swiss Group for Clinical Cancer Research (SAKK) – Breast Cancer Project Group

2006 ◽  
Vol 9 (S1) ◽  
pp. 419-429
Author(s):  
Keyword(s):  
Breast Cancer ◽  
Cancer Research ◽  
Clinical Trials ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Metastatic Breast ◽  
Advanced Breast ◽  
Clinical Cancer Research ◽  
Cancer Project

This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Swiss Group for Clinical Cancer Research (SAKK) – Breast Cancer Project Group. Clinical trials include: Randomized phase III trial of Herceptin followed by chemotherapy plus Herceptin versus the combination of Herceptin and chemotherapy as palliative treatment in patients with HER2-overexpressing advanced/metastatic breast cancer. Protocol SAKK 22/99Trastuzumab monotherapy followed by the combination of trastuzumab and letrozole in post-menopausal women with ER-positive, HER-2 positive advanced breast cancer resistant to a nonsteroidal aromatase inhibitor. A multicenter two-step phase II trial Protocol SAKK 23/03Phase I–II trial of capecitabine and vinorelbine in elderly patients ( 65 years) with metastatic breast cancer with and without bone involvement. Protocol SAKK 25/99Phase I/II trial of capecitabine with weekly paclitaxel for advanced breast cancer. Protocol SAKK 26/00

A Hopeful Discovery in Cancer Research

1949 ◽  
Vol 12 (4) ◽  
pp. 700-701
Author(s):  
W.C.A.
Keyword(s):  
Cancer Research
Sign in / Sign up

Export Citation Format

Share Document